1. Home
  2. MRVI vs DCBO Comparison

MRVI vs DCBO Comparison

Compare MRVI & DCBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • DCBO
  • Stock Information
  • Founded
  • MRVI 2020
  • DCBO 2016
  • Country
  • MRVI United States
  • DCBO Canada
  • Employees
  • MRVI N/A
  • DCBO N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • DCBO
  • Sector
  • MRVI Health Care
  • DCBO
  • Exchange
  • MRVI Nasdaq
  • DCBO Nasdaq
  • Market Cap
  • MRVI 1.2B
  • DCBO 1.3B
  • IPO Year
  • MRVI 2020
  • DCBO 2020
  • Fundamental
  • Price
  • MRVI $4.42
  • DCBO $46.83
  • Analyst Decision
  • MRVI Buy
  • DCBO Strong Buy
  • Analyst Count
  • MRVI 11
  • DCBO 7
  • Target Price
  • MRVI $10.33
  • DCBO $54.71
  • AVG Volume (30 Days)
  • MRVI 2.5M
  • DCBO 74.2K
  • Earning Date
  • MRVI 11-07-2024
  • DCBO 11-08-2024
  • Dividend Yield
  • MRVI N/A
  • DCBO N/A
  • EPS Growth
  • MRVI N/A
  • DCBO 1403.35
  • EPS
  • MRVI N/A
  • DCBO 0.56
  • Revenue
  • MRVI $276,920,000.00
  • DCBO $209,170,000.00
  • Revenue This Year
  • MRVI N/A
  • DCBO $20.98
  • Revenue Next Year
  • MRVI $7.10
  • DCBO $15.49
  • P/E Ratio
  • MRVI N/A
  • DCBO $78.41
  • Revenue Growth
  • MRVI N/A
  • DCBO 22.67
  • 52 Week Low
  • MRVI $4.39
  • DCBO $33.81
  • 52 Week High
  • MRVI $11.56
  • DCBO $56.41
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 26.26
  • DCBO 47.11
  • Support Level
  • MRVI $4.71
  • DCBO $44.94
  • Resistance Level
  • MRVI $6.34
  • DCBO $51.19
  • Average True Range (ATR)
  • MRVI 0.49
  • DCBO 1.64
  • MACD
  • MRVI -0.27
  • DCBO -0.24
  • Stochastic Oscillator
  • MRVI 0.77
  • DCBO 21.19

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About DCBO Docebo Inc.

Docebo Inc is a provider of cloud-based learning management systems.. The solutions provided by the company are sold on a subscription model and subscriptions are typically structured with an initial fixed term of between one and three years, without the ability for customers to terminate for convenience. The company charges its customers based on a per-learner, per-module basis, varying depending on the size of the organization and complexity. The majority of the revenue is derived from customers based in North America.

Share on Social Networks: